UAB and Mereo Announce Positive Top-line Results from “COSTA” a Phase 1b/2 Trial of Alvelestat (MPH966) in Hospitalized Patients with COVID-19 Respiratory DiseaseGlobeNewsWire • 12/22/21
Biomarker Data from Phase 1b/2 Investigator-sponsored Trial of Mereo's Alvelestat in Bronchiolitis Obliterans Syndrome (BOS) at the ASH Annual MeetingGlobeNewsWire • 12/13/21
Mereo BioPharma's Etigilimab/Opdivo Combo Achieves One Complete Response In Cervical CancerBenzinga • 11/30/21
Data from Investigator-sponsored Trial of Mereo BioPharma's alvelestat in Bronchiolitis Obliterans Syndrome (BOS) Accepted for Presentation at American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 11/04/21
Mereo BioPharma Announces Appointment of Pierre Jacquet, M.D., Ph.D. to Board of DirectorsGlobeNewsWire • 09/20/21
Mereo's Alvelestat Shows Encouraging Biomarker Data In Bronchiolitis Obliterans SyndromeBenzinga • 06/02/21
Mereo BioPharma to Present at the 20th Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/08/21
Mereo BioPharma Reports Full Year 2020 Financial Results and Recent HighlightsGlobeNewsWire • 03/31/21
Mereo BioPharma to Participate in a Fireside Chat at the 10th Annual SVB Leerink Global Healthcare ConferenceGlobeNewsWire • 02/18/21
Mereo BioPharma Group plc Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional American Depositary SharesGlobeNewsWire • 02/12/21
Mereo BioPharma Group plc Announces Pricing of Public Offering of American Depositary SharesGlobeNewsWire • 02/10/21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary SharesGlobeNewsWire • 02/09/21
Mereo BioPharma and Ultragenyx Announce Collaboration and License Agreement for Setrusumab in Osteogenesis ImperfectaGlobeNewsWire • 12/17/20
Mereo BioPharma Provides Update on AIM Delisting and Continued Listing of its ADSs on Nasdaq, and Provides Update on agreements with Silicon Valley Bank and Kreos CapitalGlobeNewsWire • 12/15/20
Mereo BioPharma Appoints Suba Krishnan, M.D. as Senior Vice President of Clinical DevelopmentGlobeNewsWire • 11/23/20
Mereo BioPharma Appoints Christine Fox as Chief Financial Officer and Heidi Petersen as Senior Vice President, Regulatory AffairsGlobeNewsWire • 10/20/20